# Sands Capital Alternatives, LLC: Form 13F holdings

An institutional investment manager in ARLINGTON, VA. SEC CIK 1846444.

- Quarter ended: 2026-06-30
- Filed: 2026-08-13
- Reported value: $613.5m
- Positions: 24 (24 lines in the filing's table; lines for the same security and option type are added together here)
- Compared with: the 13F for the quarter ended 2026-03-31
- Filing: https://www.sec.gov/Archives/edgar/data/1846444/000184644426000009/

## Holdings

As filed, largest first. Reported value is what the manager stated at the quarter end (Jun 30, 2026), in US dollars; it is filing data, not a price. Weight is the share of the total reported value.

| Issuer | Class | Reported value | Weight | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | ---: | --- | --- |
| [ALAMAR BIOSCIENCES INC (ALMR)](/companies/almr.md) | COMMON STOCK | $114.6m | 18.7% | 4,230,926 |  | New +4,230,926 |
| NU HLDGS LTD | ORD SHS CL A | $94.8m | 15.4% | 7,094,952 |  | Added +557,183 |
| [KLAVIYO INC (KVYO)](/companies/kvyo.md) | COM SER A | $59.3m | 9.7% | 3,928,146 |  | Added +278,468 |
| [BETA BIONICS INC (BBNX)](/companies/bbnx.md) | COM | $58.1m | 9.5% | 3,708,043 |  | Unchanged |
| [SPYGLASS PHARMA INC (SGP)](/companies/sgp.md) | COM SHS | $55.7m | 9.1% | 2,500,012 |  | Unchanged |
| [INHIBIKASE THERAPEUTICS INC (IKT)](/companies/ikt.md) | COM NEW | $26.4m | 4.3% | 13,018,965 |  | Unchanged |
| [DOORDASH INC (DASH)](/companies/dash.md) | CL A | $23.5m | 3.8% | 127,562 |  | Added +16,331 |
| [COUPANG INC (CPNG)](/companies/cpng.md) | CL A | $23.1m | 3.8% | 1,329,314 |  | Added +317,223 |
| [DATADOG INC (DDOG)](/companies/ddog.md) | CL A COM | $21.1m | 3.4% | 80,851 |  | Reduced −4,942 |
| [BIOAGE LABS INC (BIOA)](/companies/bioa.md) | COM | $19.3m | 3.1% | 786,353 |  | Unchanged |
| [10X GENOMICS INC (TXG)](/companies/txg.md) | CL A COM | $18.5m | 3.0% | 481,770 |  | Unchanged |
| [SAMSARA INC (IOT)](/companies/iot.md) | COM CL A | $16.7m | 2.7% | 515,658 |  | Reduced −44,629 |
| [ODYSSEY THERAPEUTICS INC (ODTX)](/companies/odtx.md) | COMMON STOCK | $16.4m | 2.7% | 875,000 |  | New +875,000 |
| [TOAST INC (TOST)](/companies/tost.md) | CL A | $10.2m | 1.7% | 364,879 |  | Added +63,232 |
| [ACUMEN PHARMACEUTICALS INC (ABOS)](/companies/abos.md) | COM | $9.9m | 1.6% | 3,720,105 |  | Unchanged |
| [SERVICETITAN INC (TTAN)](/companies/ttan.md) | SHS CL A | $7.7m | 1.3% | 108,545 |  | Added +18,689 |
| [CEREBRAS SYSTEMS INC (CBRS)](/companies/cbrs.md) | COM CL A | $7.3m | 1.2% | 32,825 |  | New +32,825 |
| [SNOWFLAKE INC (SNOW)](/companies/snow.md) | COM SHS | $6.2m | 1.0% | 24,498 |  | Added +4,245 |
| MONDAY COM LTD | SHS | $5.9m | 1.0% | 81,982 |  | Added +14,114 |
| [TARSUS PHARMACEUTICALS INC (TARS)](/companies/tars.md) | COM | $5.3m | 0.9% | 85,000 |  | Unchanged |
| [TAYSHA GENE THERAPIES INC (TSHA)](/companies/tsha.md) | COM SHS | $4.9m | 0.8% | 724,873 |  | Unchanged |
| [CANDEL THERAPEUTICS INC (CADL)](/companies/cadl.md) | COM | $4.2m | 0.7% | 405,837 |  | Unchanged |
| [ACRIVON THERAPEUTICS INC (ACRV)](/companies/acrv.md) | COMMON STOCK | $4.1m | 0.7% | 2,289,271 |  | Added +166,666 |
| [FIGMA INC (FIG)](/companies/fig.md) | CLASS A COM STK | $401.0k | <0.1% | 22,165 |  | Added +3,879 |

Source: SEC EDGAR, Form 13F-HR, accession 0001846444-26-000009. Last ingested by Listed: Oct 22, 2026, 05:26 ET. No prices; not investment advice.